AKSO HEALTH GR. (SPADR)/3 Cash Flow-to-Debt Ratio
AKSO HEALTH GR. (SPADR)/3 cash flow-to-debt ratio. AKSO HEALTH GR. (SPADR)/3 (8HX) has a Cash Flow-to-Debt Ratio of 0.07x as of March 2025, meaning its operating cash flow of €1.18 Million could theoretically repay 0% of its total liabilities (€15.80 Million) in one year. Check AKSO HEALTH GR. (SPADR)/3 (8HX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of AKSO HEALTH GR. (SPADR)/3 (2022–2025)
Cash flow-to-debt ratio of AKSO HEALTH GR. (SPADR)/3 from 2022 to 2025. Historical debt coverage capacity for AKSO HEALTH GR. (SPADR)/3 across 4 annual periods. See AKSO HEALTH GR. (SPADR)/3 net asset quality index to measure how much of total assets are equity-financed.
AKSO HEALTH GR. (SPADR)/3 Cash Flow-to-Debt Ratio by Year (2022–2025)
AKSO HEALTH GR. (SPADR)/3 cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for AKSO HEALTH GR. (SPADR)/3. For the full cash flow conversion analysis, see cash efficiency ratio of AKSO HEALTH GR. (SPADR)/3.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | €1.18 Million | €15.80 Million | ▼ -80.2% |
| 2024 | 0.38x | €1.35 Million | €3.59 Million | ▲ +234.3% |
| 2023 | -0.28x | €-3.25 Million | €11.62 Million | ▼ -63.9% |
| 2022 | -0.17x | €-8.63 Million | €50.52 Million | — |